Background The IMpower110 trial revealed that atezolizumab treatment had significantly
longer overall survival (OS) than chemotherapy in non-small cell lung cancer (NSCLC) …

Lung cancer is the number one cause of cancer-related deaths in the United States as well
as worldwide. Radiologists and physicians experience heavy daily workloads, thus are at …

Abstract Background Never smokers in Asia have a higher incidence of lung cancer than in
Europe and North America. We aimed to assess the cost-effectiveness of lung cancer …

Background There are limited data on the cost-effectiveness of smoking cessation
interventions in lung cancer screening settings. We conducted an economic analysis …

Background Numerous health policy organizations recommend lung cancer screening, but
no consensus exists on the optimal policy. Moreover, the impact of the Lung CT screening …

Abstract Background The Lung Computed Tomography Screening Reporting and Data
System (Lung-RADS) reduces the false-positive rate of lung cancer screening but introduces …

Background Detailed cost estimates are not widely available for esophageal cancer. Our
study estimates phase‐specific costs for esophageal cancer by age, year, histology, stage …

Background Less is known about the impact of cancer on household assets and household
financial portfolio during which cancer survivors face higher mortality risk. Economic theory …

Objective We developed a novel approach for localization and resection of lung nodules,
using image‐guided video‐assisted thoracoscopic surgery (iVATS). We report our …

Background & Aims Hepatocellular carcinoma (HCC) has an increasing mortality in the
United States and is a leading cause of morbidity and mortality in patients with cirrhosis. We …